We are live on ! Find out more
DTIL icon

Precision BioSciences
DTIL

51 hedge funds and large institutions have $29.8M invested in Precision BioSciences in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

9% more funds holding

Funds holding: 47 → 51 (+4)

0.35% more ownership

Funds ownership: 45.62% → 45.97% (+0.35%)

3% less capital invested

Capital invested by funds: $30.8M → $29.8M (-$962K)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
51
Holders Change
+4
Holders Change %
+8.51%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
7
Increased
11
Reduced
9
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$664K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$379K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$320K
4
Northern Trust
Northern Trust
Illinois
+$259K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$184K

Top Sellers

Rank Fund Capital Flow
1
MSAM
Moloney Securities Asset Management
Missouri
-$168K
2
RWMG
Redwood Wealth Management Group
New Jersey
-$150K
3
Stifel Financial
Stifel Financial
Missouri
-$88.4K
4
TRCT
Tower Research Capital (TRC)
New York
-$31.1K
5
Renaissance Technologies
Renaissance Technologies
New York
-$23.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
AF
26
Allworth Financial
California
$42.7K – – –
VC
27
Vivo Capital
California
$41.9K – – –
Barclays
28
Barclays
United Kingdom
$25.7K – – –
Osaic Holdings
29
Osaic Holdings
Arizona
$21.1K +$1.93K +200 +9%
UBS Group
30
UBS Group
Switzerland
$16.9K +$16.1K +1,676 +810%
TRCT
31
Tower Research Capital (TRC)
New York
$4.2K -$31.1K -3,227 -87%
Wells Fargo
32
Wells Fargo
California
$3K – – –
RhumbLine Advisers
33
RhumbLine Advisers
Massachusetts
$2.46K +$2.65K +275 New
Zurich Cantonal Bank
34
Zurich Cantonal Bank
Switzerland
$2.31K -$241 -25 -9%
BNP Paribas Financial Markets
35
BNP Paribas Financial Markets
France
$1.36K – – –
Fidelity Investments
36
Fidelity Investments
Massachusetts
$1.12K +$1.2K +125 New
Lazard Asset Management
37
Lazard Asset Management
New York
$1K +$347 +36 +44%
SC
38
SouthState Corp
Florida
$851 – – –
AWM
39
Ameliora Wealth Management
Switzerland
$296 – – –
NA
40
NewEdge Advisors
Louisiana
$194 – – –
FDCDDQ
41
Federation des caisses Desjardins du Quebec
Quebec, Canada
$108 -$19 -2 -14%
M
42
MOTCO
Texas
$90 – – –
IRC
43
Investors Research Corp
Georgia
$72 – – –
JP Morgan Chase
44
JP Morgan Chase
New York
$72 – – –
HI
45
Harbour Investments
Wisconsin
$27 – – –
Northwestern Mutual Wealth Management
46
Northwestern Mutual Wealth Management
Wisconsin
$27 +$29 +3 New
LIS
47
Legacy Investment Solutions
Idaho
$25 +$29 +3 New
LWMI
48
Legacy Wealth Management (Idaho)
Idaho
$25 +$29 +3 New
Citigroup
49
Citigroup
New York
$9 – – –
GWSG
50
GPS Wealth Strategies Group
Colorado
$9 – – –
1
2
3

DTIL Hedge Fund Activity: Q3 2024 in Review

51 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q3 2024, worth a combined $29.8M — down 3.1% from $30.8M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new DTIL positions and 3 closed out — a net gain of 4 holders — while 11 added to existing stakes and 9 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $664K. The largest seller was Moloney Securities Asset Management, cutting an estimated $168K.

  • 51 institutional investors held Precision BioSciences (DTIL) as of Q3 2024, up from 47 in Q2 2024.
  • Funds reported $29.8M of Precision BioSciences stock for Q3 2024, down 3.1% quarter-over-quarter.
  • 7 funds opened new Precision BioSciences positions in Q3 2024 and 3 closed out, a net change of +4 holders.
  • The largest Precision BioSciences buyer in Q3 2024 was Janus Henderson Group, an estimated $664K added.
  • The largest Precision BioSciences seller in Q3 2024 was Moloney Securities Asset Management, an estimated $168K sold.

Based on aggregated 13F filings for Q3 2024.